31 results
Thumbnail

D1.39 - Differential Diagnosis of Perioperative Anaphylaxis: The Hidden Role of Chlorhexidine

Thumbnail

D1.28 - Anaphylaxis after appendectomy: A case of allergy to sugammadex

Thumbnail

D1.29 - Class III Chitinases as Potential Allergens in Raspberry-Induced Anaphylaxis

Thumbnail

D1.30 - An exotic anaphylaxis in the mediterranean: due to a clinical case

Thumbnail

D1.31 - Quality Of Life In Alexithymic Patients With Anaphylaxis

Thumbnail

D1.32 - The effect of chelation on carmine allergy induced by epicutaneous sensitization to carmine in cosmetics

Thumbnail

D1.33 - Oat Allergy in a Young Adult: Allergenic Protein Profiling and Clinical Implications

Thumbnail

D1.34 - Hypersensitivity Reactions to Iodinated and Gadolinium-Based Contrast Media: Clinical and Epidemiological Insights

Thumbnail

D1.35 - Lipid transfer protein and Profilin-associated food-dependent exercise-induced anaphylaxis: A case series

Thumbnail

D1.36 - Prevalence of thaumatin and Alternaria co-sensitization

Thumbnail

D1.42 - Case Report of Allergy to Mint and Basil

Thumbnail

D1.43 - Performance Evaluation of a Semi-Quantitative Rapid Test Kit for Dust Mites: For Home Self-Monitoring and Control Effectiveness Assessment

Thumbnail

D1.37 - Sometimes it is not what it seems

Thumbnail

D1.38 - Anaphylactic reaction to chia seeds: A case report

Thumbnail

D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data

Thumbnail

D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases

Thumbnail

D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin

Thumbnail

D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity

Thumbnail

D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis

Thumbnail

D3.415 - Clinical manifestations of Hereditary alpha-tryptasemia (HaT) in Patients with Mast Cell Activation Syndromes